Surgical Specialty Training:
Edward Boyle, MD, has a career that spans clinical surgery, vascular research, and medical innovation. After graduating from the University of Minnesota Medical School in Minneapolis, Dr. Boyle completed his surgical training at the University of Washington in Seattle. This included completion of residency training in surgery and sub specialization in cardiovascular and thoracic surgery. During his tenure at the University of Washington, Dr. Boyle also completed a cardiovascular research fellowship. In this setting he developed basic science and clinical research programs, primarily focusing on blood vessel disorders at a basic science level. After starting out his career specializing in cardiothoracic surgery, he now sub specializes entirely in treating patients with vein and vascular disorders.
Research Experience and Awards:
As a researcher Dr. Edward Boyle has published over 90 manuscripts in peer reviewed medical journals and textbooks. In addition, he is an inventor on over 20 US and international patents. He has received research awards from the American College of Surgeons, the American Heart Association, the Western Thoracic Surgery Association and the Seattle Surgical Society in addition to innovation awards from the European Association of Cardiothoracic Surgeons, the Gold Medical Design Excellence Award, ID Design Distinction, a Spark Award, and a Good Design Award. His work has also been cited on the R&D 100 list, which salutes the 100 most technologically significant products introduced into the marketplace. He was also the recipient of the Innovations in Cardiovascular Interventions (ICI) award for developing Pleuraflow, a device used to improve outcomes for patients recovering after heart and lung surgery.
In addition to his clinical work, Dr. Boyle is active in surgical innovation where he has experience developing medical devices from idea state through commercialization. Dr. Boyle was a founder of Elixis, a healthcare information technology company. This company was acquired by Data Critical Corporation (NASDAQ: DCCA), now a division of General Electric (NYSE: GE). Dr. Boyle is a founder of ClearFlow Medical, Precision Thoracic Corporation and VenX, all early stage medical device companies where he was an inventor of medical devices that relate to minimally invasive surgical techniques or process improvements in healthcare. Recently, he co-founded Enhanced Recovery after Surgery (ERAS) Cardiac Surgery, a not-for-profit patient safety organization with the mission is to optimize perioperative care of surgical patients through collaborative discovery, analysis, expert consensus, and dissemination of best practices.
Above all, however, his interest is patients with the highest value care in a caring, convenient setting. Being involved in ongoing innovation, therefore, at a national and international level, allows him to stay up to date with the latest or soon to be available treatments. This facilitates his ability to provide patients with the most up to date, innovative approaches for their care needs.